Premier Asset Management LLC Global Blood Therapeutics, Inc. Transaction History

Premier Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $1.61 Million - $2.36 Million	-63,319 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $1.75 Million - $2.33 Million	53,775 Added 563.44%	63,319 $2.22 Million
Q1 2021 May 12, 2021	SELL	$38.94 - $50.85 $552,636 - $721,663	-14,192 Reduced 59.79%	9,544 $389,000
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $893,660 - $1.51 Million	23,736 New	23,736 $1.03 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $817,515 - $1.09 Million	-20,443 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$31.54 - $46.67 $644,772 - $954,074	20,443 New	20,443 $839,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.